Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Oklahoma Capital Investment Board (OCIB) is a quasi-governmental agency established by the State of Oklahoma to mobilize equity and near-equity capital for Oklahoma businesses. It operates primarily as a "fund of funds," investing in venture capital and private equity funds that, in turn, invest in companies across various sectors, including biotechnology and healthcare. OCIB utilizes a unique tax credit program to guarantee investments, aiming to foster economic development and job creation within the state. While not a life sciences company itself, it has been a significant source of indirect funding for Oklahoma's emerging biotech ecosystem. The board is currently managed under the administrative umbrella of the Oklahoma Development Finance Authority.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oklahoma Capital Investment Board.